| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |